Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-23T13:51:18.599Z Has data issue: false hasContentIssue false
  • English
  • Français

Neurocognitive disorders: Cluster 1 of the proposed meta-structure for DSM-V and ICD-11

Paper 2 of 7 of the thematic section: ‘A proposal for a meta-structure for DSM-V and ICD-11’

Published online by Cambridge University Press:  01 October 2009

P. Sachdev ,
G. Andrews ,
M. J. Hobbs ,
M. Sunderland  and
T. M. Anderson
P. Sachdev*
Affiliation:
School of Psychiatry, University of New South Wales, Sydney, Australia
G. Andrews
Affiliation:
School of Psychiatry, University of New South Wales, Sydney, Australia
M. J. Hobbs
Affiliation:
School of Psychiatry, University of New South Wales, Sydney, Australia
M. Sunderland
Affiliation:
School of Psychiatry, University of New South Wales, Sydney, Australia
T. M. Anderson
Affiliation:
School of Psychiatry, University of New South Wales, Sydney, Australia
*
*Address for correspondence: Professor P. Sachdev, Neuropsychiatric Institute, The Prince of Wales Hospital, Randwick NSW 2031, Australia. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

In an effort to group mental disorders on the basis of aetiology, five clusters have been proposed. In this paper, we consider the validity of the first cluster, neurocognitive disorders, within this proposal. These disorders are categorized as ‘Dementia, Delirium, and Amnestic and Other Cognitive Disorders’ in DSM-IV and ‘Organic, including Symptomatic Mental Disorders’ in ICD-10.

Method

We reviewed the literature in relation to 11 validating criteria proposed by a Study Group of the DSM-V Task Force as applied to the cluster of neurocognitive disorders.

Results

‘Neurocognitive’ replaces the previous terms ‘cognitive’ and ‘organic’ used in DSM-IV and ICD-10 respectively as the descriptor for disorders in this cluster. Although cognitive/organic problems are present in other disorders, this cluster distinguishes itself by the demonstrable neural substrate abnormalities and the salience of cognitive symptoms and deficits. Shared biomarkers, co-morbidity and course offer less persuasive evidence for a valid cluster of neurocognitive disorders. The occurrence of these disorders subsequent to normal brain development sets this cluster apart from neurodevelopmental disorders. The aetiology of the disorders is varied, but the neurobiological underpinnings are better understood than for mental disorders in any other cluster.

Conclusions

Neurocognitive disorders meet some of the salient criteria proposed by the Study Group of the DSM-V Task Force to suggest a classification cluster. Further developments in the aetiopathogenesis of these disorders will enhance the clinical utility of this cluster.

Keywords

ClassificationdementiadeliriumDSM-VICD-11mild cognitive impairmentneurocognitive disorders
Type
Thematic section: A proposal for a meta-structure for DSM-V and ICD-11
Information
Psychological Medicine , Volume 39 , Issue 12 , December 2009 , pp. 2001 - 2012
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alexopoulos, GS (2003). Vascular disease, depression, and dementia. Journal of the American Geriatrics Society 51, 1178–1180.Google Scholar
Alexopoulos, GS, Meyers, BS, Young, RC, Campbell, S, Silbersweig, D, Charlson, M (1997). ‘Vascular depression’ hypothesis. Archives of General Psychiatry 54, 915–922.Google Scholar
Andrews, G, Goldberg, DP, Krueger, RF, Carpenter, Jr. WT, Hyman, SE, Sachdev, P, Pine, DS (2009 a). Exploring the feasibility of a meta-structure for DSM-V and ICD-11: could it improve utility and validity? Psychological Medicine. doi:10.1017/S0033291709990250.Google Scholar
Andrews, G, Pine, DS, Hobbs, MJ, Anderson, TM, Sunderland, M (2009 b). Neurodevelopmental disorders: Cluster 2 of the proposed meta-structure for DSM-V and ICD-11. Psychological Medicine. doi:10.1017/S0033291709990274.Google Scholar
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn.American Psychiatric Association: Washington, DC.Google Scholar
Armstrong, RA, Lantos, PL, Cairns, NJ (2005). Overlap between neurodegenerative disorders. Neuropathology 25, 111–124.Google Scholar
Ashburner, J, Csernansky, JG, Davatzikos, C, Fox, NC, Frisoni, GB, Thompson, PM (2003). Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurology 2, 79–86.Google Scholar
Beck, AT (1975). Cognitive Therapy and the Emotional Disorders. International Universities Press: New York, NY.Google Scholar
Bleecker, ML, Ford, DP, Lindgren, KN, Hoese, VM, Walsh, KS, Vaughan, CG (2005). Differential effects of lead exposure on components of verbal memory. Occupational Environmental Medicine 62, 181–187.Google Scholar
Boutros, NN, Struve, F (2002). Electrophysiological stageing of Alzheimer-related changes. Acta Neuropathologica 82, 239–259.Google Scholar
Braak, H, Braak, E (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 82, 239–259.Google Scholar
Braak, H, Ghebremedhin, E, Rub, U, Bratzke, H, Del Tredici, K (2004). Stages in the development of Parkinson's disease-related pathology. Cell and Tissue Research 318, 121–134.Google Scholar
Brookmeyer, R, Corrada, MM, Curriero, FC, Kawas, C (2002). Survival following a diagnosis of Alzheimer disease. Archives of Neurology 59, 1764–1767.Google Scholar
Burns, A, Gallagley, A, Byrne, J (2004). Delirium. Journal of Neurology, Neurosurgery and Psychiatry 75, 362–367.Google Scholar
Caspi, A, McCray, J, Moffitt, TE, Mill, J, Martin, J, Craig, IW, Taylor, A, Poulton, R (2002). Role of genotype in the cycle of violence in maltreated children. Science 297, 851–854.Google Scholar
Caspi, A, Moffitt, TE (2006). Gene–environment interactions in psychiatry: joining forces with neuroscience. Nature Reviews Neuroscience 7, 583–590.Google Scholar
Caspi, A, Sugden, K, Moffitt, TE, Taylor, A, Craig, IW, Harrington, H, McClay, J, Mill, J, Martin, J, Braithwaite, A, Poulton, R (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386–389.Google Scholar
Chertkow, H, Black, S (2007). Imaging biomarkers and their role in dementia clinical trials. Canadian Journal of Neurological Sciences 34 (Suppl. 1), S77–S83.Google Scholar
Cole, MG (2004). Delirium in elderly patients. American Journal of Geriatric Psychiatry 12, 7–21.Google Scholar
Coppus, A, Evenhuis, H, Verberne, G-J, Visser, F, van Gool, P, Eikelenboom, P, van Duijin, C (2006). Dementia and mortality in persons with Down's syndrome. Journal of Intellectual Disability Research 50, 768–777.Google Scholar
Erkinjuntti, T, Roman, G, Gauthier, S (2004). Treatment of vascular dementia – evidence from clinical trials with cholinesterase inhibitors. Journal of the Neurological Sciences 226, 63–66.Google Scholar
Ertekin-Taner, N (2007). Genetics of Alzheimer's disease: a centennial review. Neurologic Clinics 25, 611–667.Google Scholar
Fick, DM, Agostini, JV, Inouye, SK (2002). Delirium superimposed on dementia: a systematic review. Journal of the American Geriatrics Society 50, 1723–1732.Google Scholar
Green, AJ (2002). Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt–Jakob disease. Neuropathology and Applied Neurobiology 28, 427–440.Google Scholar
Gusella, JF, MacDonald, ME (1996). Trinucleotide instability: a repeating theme in human inherited disorders. Annual Review of Medicine 47, 201–209.Google Scholar
Hainfellner, JA, Wanschitz, J, Jellinger, K, Liberski, PP, Gullotta, F, Budka, H (1998). Coexistence of Alzheimer-type neuropathology in Creutzfeldt–Jakob disease. Acta Neuropathologica 96, 116–122.Google Scholar
Halliwell, B (2006). Oxidative stress and neurodegeneration: where are we now? Journal of Neurochemistry 97, 1634–1658.Google Scholar
Harding, A, Halliday, G, Caine, D, Kril, J (2000). Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia. Brain 123, 141–154.Google Scholar
Harper, C (2007). The neurotoxicity of alcohol. Human and Experimental Toxicology 26, 251–257.Google Scholar
Harrison, PJ (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122, 593–624.Google Scholar
Hebert, R, Lindsay, J, Verreault, R, Rockwood, K, Hill, G, Dubois, M-F (2000). Vascular dementia: incidence and risk factors in the Canadian Study of Health and Aging. Stroke 31, 1487–1493.Google Scholar
Hogan, DB, Patterson, C (2002). Progress in clinical neurosciences: Treatment of Alzheimer's disease and other dementias – review and comparison of the cholinesterase inhibitors. Canadian Journal of Neurological Sciences 29, 306–314.Google Scholar
Holland, AJ, Hon, J, Huppert, FA, Stevens, F (2000). Incidence and course of dementia in people with Down's syndrome: findings from a population-based study. Journal of Intellectual Disability Research 44, 138–146.Google Scholar
Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971–983.Google Scholar
Ince, PG (2001). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357, 169–175.Google Scholar
Inouye, SK (1999). Predisposing and precipitating factors for delirium in hospitalized older patients. Dementia and Geriatric Cognitive Disorders 10, 393–400.Google Scholar
Inouye, SK, Rushing, JT, Foreman, MD, Palmer, RM, Pompei, P (1998). Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. Journal of General Internal Medicine 13, 234–242.Google Scholar
Iregren, A (2006). Behavioral toxicology: from historical background to future trends. Medicina del Lavoro 97, 332–338.Google Scholar
Jorm, AF, Korten, A, Henderson, AS (1987). The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatrica Scandinavica 76, 465–479.Google Scholar
Kalaria, RN, Ballard, C (1999). Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Disease and Associated Disorders 13, S115–S123.Google Scholar
Katz, R (2004). Biomarkers and surrogate markers: an FDA perspective. NeuroRx 1, 89–95.Google Scholar
Klunk, WE, Engler, H, Nordberg, A, Wang, Y, Blomqvist, G, Holt, DP, Bergstrom, M, Savitcheva, I, Huang, G, Estrada, S, Ausen, B, Debnath, ML, Barletta, J, Price, JC, Sandell, J, Lopresti, BJ, Wall, A, Koivisto, P, Antoni, G, Mathis, CA, Langstrom, B (2004). Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurology 55, 306–319.Google Scholar
Kopelman, MD (2002). Disorders of memory. Brain 125, 2152–2190.Google Scholar
Krueger, RF (1999). The structure of common mental disorders. Archives of General Psychiatry 56, 921–926.Google Scholar
Krueger, RF, Markon, KE (2006). Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology. Annual Reviews in Clinical Psychology 2, 111–133.Google Scholar
Langston, JW, Forno, LS, Tetrud, J, Reeves, AG, Kaplan, JA, Karluk, D (1999). Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Annals of Neurology 46, 598–605.Google Scholar
Lanphear, BP, Hornung, R, Khoury, J, Yolton, K, Baghurst, P, Belinger, DC, Canfield, RL, Dietrich, KN, Bornschein, R, Greeme, T, Rothenberg, SJ, Needleman, HL, Schnaas, L, Wasserman, G, Graziano, J, Roberts, R (2005). Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environmental Health Perspectives 113, 894–899.Google Scholar
Lebert, F, Pasquier, F, Petit, H (1995). Personality traits and frontal lobe dementia. International Journal of Geriatric Psychiatry 10, 1047–1049.Google Scholar
Leentjens, AFG, van der Mast, RC (2005). Delirium in elderly people: an update. Current Opinion in Psychiatry 18, 325–330.Google Scholar
Lezak, MD, Howieson, DB, Loring, DW (2004). Neuropsychological Assessment, 4th edn.Oxford University Press: Oxford.Google Scholar
Li, Y, Grupe, A (2007). Genetics of late-onset Alzheimer's disease: progress and prospect. Pharmacogenomics 8, 1747–1755.Google Scholar
Lishman, WA (1998). Organic Psychiatry: The Psychological Consequences of Cerebral Disorder, 3rd edn.Blackwell Science: Oxford.Google Scholar
Low, LF, Brodaty, H, Draper, B (2002). A study of premorbid personality and behavioural and psychological symptoms of dementia in nursing home residents. International Journal of Geriatric Psychiatry 17, 779–783.Google Scholar
Lyketsos, C (2006). Lessons from neuropsychiatry. Journal of Neuropsychiatry and Clinical Neurosciences 18, 445–449.Google Scholar
Marin, DB, Breuer, B, Marin, ML, Silverman, J, Schmeidler, J, Greenberg, D, Flynn, S, Mare, M, Lantz, M, Libow, L, Neufeld, R, Altstiel, L, Davis, KL, Mohs, RC (1998). The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis 140, 173–180.Google Scholar
McCusker, J, Cole, M, Dendukuri, N, Han, L, Belzile, E (2003). The course of delirium in older medical inpatients: a prospective study. Journal of General Internal Medicine 18, 696–704.Google Scholar
Meins, W, Dammast, J (2000). Do personality traits predict the occurrence of Alzheimer's disease? International Journal of Geriatric Psychiatry 15, 120–124.Google Scholar
Meins, W, Frey, A, Thiesemann, R (1998). Premorbid personality traits in Alzheimer's disease: do they predispose to noncognitive behavioral symptoms? International Psychogeriatrics 10, 369–378.Google Scholar
Morrison, JH, Hof, PR (1997). Life and death of neurons in the aging brain. Science 278, 412–419.Google Scholar
Nathoo, N, Chetty, R, van Dellen, JR, Barnett, GH (2003). Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E. Molecular Pathology 56, 132–136.Google Scholar
Otto, M, Esselmann, H, Schulz-Schaeffer, W, Neumann, M, Schroter, A, Ratzka, P, Cepek, L, Zerr, I, Steinacker, P, Windl, O, Kornhuber, J, Kretzschmar, HA, Poser, S, Wiltfang, J (2000). Decreased β-amyloid 1-42 in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease. Neurology 54, 1099–1102.Google Scholar
Otto, M, Wiltfang, J, Tumani, H, Zerr, I, Lantsch, M, Kornhuber, J, Weber, T, Kretzschmar, HA, Poser, S (1997). Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease. Neuroscience Letters 225, 210–212.Google Scholar
Pankratz, N, Byder, L, Halter, C, Rudolph, A, Shults, CW, Conneally, PM, Foroud, T, Nichols, WC, the Parkinson Study Group-PROGENI Investigators (2006). Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Movement Disorders 21, 45–49.Google Scholar
Parchi, P, Castellani, R, Capellari, S, Ghetti, B, Young, K, Chen, SG, Farlow, M, Dickson, DW, Sima, AAF, Trojanowski, JQ, Petersen, RB, Gambetti, P (1996). Molecular basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease. Annals of Neurology 39, 767–778.Google Scholar
Parchi, P, Giese, A, Capellari, S, Brown, P, Schulz-Schaeffer, W, Windl, O, Zerr, I, Budka, H, Kopp, N, Piccardo, P, Poser, S, Rojiani, A, Streichemberger, N, Julien, J, Vital, C, Ghetti, B, Gambetti, P, Kretzschmar, H (1999). Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Annals of Neurology 46, 224–233.Google Scholar
Petersen, RC, Morris, JC (2005). Mild cognitive impairment as a clinical entity and a treatment target. Archives of Neurology 62, 1160–1163.Google Scholar
Prusiner, SB, DeArmond, SJ (1994). Prion diseases and neurodegeneration. Annual Review of Neuroscience 17, 311–339.Google Scholar
Quinette, P, Guillery-Girard, B, Dayan, J, de la Sayette, V, Marquis, S, Viader, F, Desgranges, B, Eustache, F (2006). What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain 129, 1640–1658.Google Scholar
Riepe, MW, Adler, G, Ibach, B, Weinkauf, B, Tracik, F, Gunay, I (2007). Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine. Dementia and Geriatric Cognitive Disorders 23, 301–306.Google Scholar
Robins, E, Guze, SB (1970). Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. American Journal of Psychiatry 126, 107–111.Google Scholar
Rockwood, K, Cosway, S, Carver, D, Jarrett, P, Stadnyk, K, Fisk, J (1999). The risk of dementia and death after delirium. Age and Ageing 28, 551–556.Google Scholar
Ropacki, SA, Jeste, DV (2005). Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. American Journal of Psychiatry 162, 2022–2030.Google Scholar
Sachdev, P (1996). A critique of ‘organic’ and its proposed alternatives. Australian and New Zealand Journal of Psychiatry 30, 165–170.Google Scholar
Sachdev, P (2000). Is it time to retire the term ‘dementia’? Journal of Neuropsychiatry and Clinical Neurosciences 12, 276–279.Google Scholar
Schulz, JB, Falkenburger, BH (2004). Neuronal pathology in Parkinson's disease. Cell and Tissue Research 318, 135–147.Google Scholar
Schwartz, BS, Bolla, KI, Stewart, WF, Ford, P, Agnew, J, Frumkin, H (1993). Decrements in neurobehavioral performance associated with mixed exposure to organic and inorganic lead. American Journal of Epidemiology 137, 1006–1021.Google Scholar
Siddiqi, N, Allan, O, Holmes, JD (2006). Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age and Ageing 35, 350–364.Google Scholar
Slade, T, Watson, D (2006). The structure of common DSM-IV and ICD-10 mental disorder in the Australian general population. Psychological Medicine 36, 1593–1600.Google Scholar
Strakowski, SM, DelBello, MP, Adler, CM (2005). The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Molecular Psychiatry 10, 105–116.Google Scholar
Strittmater, WJ, Roses, A (1996). Apolipoprotein E and Alzheimer's disease. Annual Review of Neuroscience 19, 53–77.Google Scholar
Tanzi, RE, Kovacs, DM, Kim, T-W, Moir, RD, Guenette, SY, Wasco, W (1996). The gene defects responsible for familial Alzheimer's disease. Neurobiology of Disease 3, 159–168.Google Scholar
Thomas, AJ, O'Brien, JT, Davis, S, Ballard, C, Barber, R, Kalaria, RN, Perry, RH (2002). Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Archives of General Psychiatry 59, 785–792.Google Scholar
Thomas, EA (2006). Striatal specificity of gene expression dysregulation in Huntington's disease. Journal of Neuroscience Research 84, 1151–1164.Google Scholar
Tyrrell, J, Cosgrave, M, McCarron, M, McPherson, J, Calvert, J, Kelly, A, McLaughlin, M, Gill, M, Lawlor, BA (2001). Dementia in people with Down's syndrome. International Journal of Geriatric Psychiatry 16, 1168–1174.Google Scholar
Valenzuela, M, Sachdev, P (2006 a). Brain reserve and dementia: a systematic review. Psychological Medicine 36, 441–454.Google Scholar
Valenzuela, M, Sachdev, P (2006 b). Brain reserve and cognitive decline: a non-parametric systematic review. Psychological Medicine 36, 1065–1073.Google Scholar
Van Den Heuvel, C, Thornton, E, Vink, R (2007). Traumatic brain injury and Alzheimer's disease: a review. Progress in Brain Research 161, 303–316.Google Scholar
van Everbrock, B, Croes, EA, Pals, P, Dermaut, B, Jansen, G, van Duijn, CM, Cruts, M, Van Broeckhoven, C, Martin, J-J, Cras, P (2001). Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt–Jakob disease phenotype. Neuroscience Letters 313, 69–72.Google Scholar
Wang, PS, Wu, YT, Hung, CI, Kwan, SY, Teng, S, Soong, BW (2008). Early detection of periodic sharp wave complexes on EEG by independent analysis in patients with Creutzfeldt–Jakob disease phenotype. Journal of Clinical Neurophysiology 25, 25–31.Google Scholar
Wiltfang, J, Lewczuk, P, Riederer, P, Grünblatt, E, Hock, C, Scheltens, P, Hampel, H, Vanderstichele, H, Iqbal, K, Galaasko, D, Lannfelt, L, Otto, M, Esselmann, H, Henkel, AW, Kornhuber, J, Blennow, K (2005). Consensus paper of the WFSBP Task Force on biological markers of dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World Journal of Biological Psychiatry 6, 69–84.Google Scholar
Wright, RO, Baccarelli, A (2007). Metals and neurotoxicology. Journal of Nutrition 137, 2809–2813.Google Scholar
Young, J, Inouye, SK (2007). Delirium in older people. British Medical Journal 334, 842–846.Google Scholar
Zakzanis, KK, Leach, L, Kaplan, E (1999). Neuropsychological Differential Diagnosis: Studies on Neuropsychology, Development and Cognition. Swets & Zeitlinger: Lisse.Google Scholar
Zipursky, RB, Meyer, JH, Verhoeff, NP (2007). PET and SPECT imaging in psychiatric disorders. Canadian Journal of Psychiatry 52, 146–157.Google Scholar